A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapy
Junbo Hu(Tongji Hospital), Paul M. Yen(Duke University), Xianmin Xia(Johns Hopkins University), Jianping Gong(Fujian Medical University), Michael F. Reed(Pennsylvania State University), Alexis A Oetting(Johns Hopkins University), Guihua Wang(Hengyang Academy of Agricultural Sciences), Aiwu Cheng(Institute on Aging), Xuelai Luo(Tongji Hospital), Tito Fojo(James J. Peters VA Medical Center)
Cited by 48
Related Papers
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits
|Proceedings of the National Academy of Sciences|2007|784
M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer
|Cancer Research|2018|672
A common pharmacophore for epothilone and taxanes: Molecular basis for drug resistance conferred by tubulin mutations in human cancer cells
|Proceedings of the National Academy of Sciences|2000|478